BANK VONTOBEL/CALL/SANOFI/84/0.1/20.12.24 Share Price

Warrant

DE000VM9UVL0

Market Closed - Deutsche Boerse AG 11:30:14 04/07/2024 pm IST
1.13 EUR +0.89% Intraday chart for BANK VONTOBEL/CALL/SANOFI/84/0.1/20.12.24
Current month+4.63%
1 month+3.67%
Date Price Change
04/24/04 1.13 +0.89%
03/24/03 1.12 0.00%
02/24/02 1.12 -9.68%
01/24/01 1.24 +14.81%
28/24/28 1.08 +6.93%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 11:30 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM9UVL
ISINDE000VM9UVL0
Date issued 06/02/2024
Strike 84
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.35
Lowest since issue 0.63
Spread 0.15
Spread %11.72%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.78%
Consensus